
Optum Rx Expands Choice, Improves Affordability for Patients With Two Additional HUMIRA Biosimilars
Starting July 1, clients of Optum Rx will have access to three biosimilar alternatives for HUMIRA, a highly utilized biologic medication used in the treatment of autoimmune diseases. The Optum Rx standard formulary will include the following treatments at parity…

















